2026 Anders Wall: Neuroscience Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Neuroscience	41	7748	7150	154	141	125	11896

Overview

Anders Wall is affiliated with Uppsala University in Sweden, focusing on research within medicine and neuroscience. Their work spans a variety of topics primarily related to brain function, neurodegenerative diseases, and advanced imaging techniques.

The main fields of study in which Wall is active include:

Medicine
Neuroscience

Subfields of study relevant to their research consist of:

Neurology
Radiology, Nuclear Medicine and Imaging
Physiology
Epidemiology
Molecular Biology

Wall's main research topics cover areas such as:

Alzheimer's disease research and treatments
Advanced MRI Techniques and Applications
Functional Brain Connectivity Studies
Traumatic Brain Injury Research
Traumatic Brain Injury and Neurovascular Disturbances
S100 Proteins and Annexins
Adrenal and Paraganglionic Tumors

Their recent published papers demonstrate the breadth of these interests. Selected works include:

"Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease" (2020, Neurology)
"Tau aggregation and increased neuroinflammation in athletes after sports-related concussions and in traumatic brain injury patients - A PET/MR study" (2021, NeuroImage Clinical)
"Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study" (2022, BMC Cardiovascular Disorders)
"Inhibitory and excitatory neurotransmitter systems in depressed and healthy: A positron emission tomography and magnetic resonance spectroscopy study" (2021, Psychiatry Research Neuroimaging)
"[18F]THK5317 imaging as a tool for predicting prospective cognitive decline in Alzheimer's disease" (2020, Molecular Psychiatry)

Wall frequently publishes in peer-reviewed venues including:

Alzheimer s & Dementia
NeuroImage Clinical
European Journal of Nuclear Medicine and Molecular Imaging
Neurology
BMC Cardiovascular Disorders

Several coauthors have collaborated regularly with Wall, reflecting ongoing research partnerships. These include:

Gunnar Antoni
Mark Lubberink
Agneta Nordberg
Niklas Marklund
Fredrik Vedung

Best Publications

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

William E. Klunk;Henry Engler;Agneta Nordberg;Yanming Wang

5340
Citations
PET imaging of amyloid deposition in patients with mild cognitive impairment

Anton Forsberg;Henry Engler;Ove Almkvist;Ove Almkvist;Ove Almkvist;Gunnar Blomquist

812
Citations
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

Henry Engler;Anton Forsberg;Ove Almkvist;Gunnar Blomquist

752
Citations
Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by 11C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining 11C-Pittsburgh Compound B and 18F-FDG

Stephen F. Carter;Michael Schöll;Ove Almkvist;Anders Wall

483
Citations
Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease

Elena Rodriguez-Vieitez;Laure Saint-Aubert;Stephen F. Carter;Ove Almkvist;Ove Almkvist;Ove Almkvist

304
Citations
Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

Annapaola Prestia;Anna Caroli;Wiesje M. van der Flier;Rik Ossenkoppele

216
Citations
PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease

Ahmadul Kadir;Ove Almkvist;Ove Almkvist;Anders Wall;Bengt Långström

207
Citations
Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers

Michael Schöll;Anders Wall;Steinunn Thordardottir;Daniel Ferreira

189
Citations
Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease

Ahmadul Kadir;Ove Almkvist;Ove Almkvist;Anton Forsberg;Anders Wall

188
Citations
Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease.

Maria Eriksdotter-Jönhagen;Bengt Linderoth;Goran Lind;Layth Aladellie

169
Citations
Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease.

Ahmadul Kadir;Niels Andreasen;Ove Almkvist;Ove Almkvist;Anders Wall

163
Citations
Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression.

Anna Caroli;Annapaola Prestia;Samantha Galluzzi;Clarissa Ferrari

153
Citations
Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer’s disease patients: application of a second-generation encapsulated cell biodelivery device

Helga Eyjolfsdottir;Helga Eyjolfsdottir;Maria Eriksdotter;Maria Eriksdotter;Bengt Linderoth;Bengt Linderoth;Göran Lind;Göran Lind

151
Citations
Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography.

Michael Schöll;Stephen F. Carter;Stephen F. Carter;Eric Westman;Elena Rodriguez-Vieitez

147
Citations
Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm

Konstantinos Chiotis;Laure Saint-Aubert;Irina Savitcheva;Vesna Jelic

146
Citations
Small-Molecule Biomarkers for Clinical PET Imaging of Apoptosis

Ayelet Reshef;Anat Shirvan;Ayelet Akselrod-Ballin;Anders Wall

137
Citations
Evidence for astrocytosis in ALS demonstrated by [11C](l)-deprenyl-D2 PET

Anders Johansson;Henry Engler;Gunnar Blomquist;Berit Scott

131
Citations
Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.

K Chiotis;L Saint-Aubert;E Rodriguez-Vieitez;A Leuzy

108
Citations
High PIB Retention in Alzheimer's Disease is an Early Event with Complex Relationship with CSF Biomarkers and Functional Parameters

A Forsberg;O Almkvist;Henry Engler;Anders Wall

104
Citations
PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD

Ahmadul Kadir;T. Darreh-Shori;Ove Almkvist;Ove Almkvist;Anders Wall

103
Citations